CLOs on the Move


 
CAIRE, Inc. is the leading respiratory care products provider for the home health care market. We manufacture a full line of Liquid Oxygen Reservoirs and Liquid Oxygen Portables. CAIRE combines product expertise and consulting to bring a unique approach
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

ENOCHS

ENOCHS is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Armetheon

Armetheon, Inc. is a privately held San Francisco Bay area-based biopharmaceutical company with late-stage clinical drug candidates in development for cardiovascular diseases. The company was founded in 2011 by experienced biotech entrepreneurs and drug developers. Armetheon’s two late-stage small molecule drug candidates are for use in the areas of oral anti-coagulation and anti-arrhythmia for atrial fibrillation. The company was founded with the idea that drug innovations can happen by building on the success of proven medications. We create solutions that are within the same class of medication and that utilize the same mechanism of action as existing therapies. This development approach has the ability to offer peace of mind to patients while benefitting physicians, who may wish to reduce safety concerns, side effects and adverse events for their patients.  

FlexMedical Disposables

FlexMedical Disposables is a Irving, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NeuroOne

NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from Epilepsy, Parkinson`s Disease, Essential Tremors and other related neurological disorders that may improve patient outcomes and reduce procedural costs.

Vicor Technology

Frp, Web: Vicor Technologies, Inc (OTCBB: VCRT) is a bio-technology company focused on the development and commercialization of innovative, non-invasive medical devices and diagnostics using its patented, proprietary PD2i® nonlinear algorithm and software to stratify patients: •at risk of sudden cardiac death or autonomic nervous system dysfunction, and •trauma victims in need of immediate lifesaving intervention.